Related Experiment Video
Updated: Nov 22, 2025

04:17
DNA Virus Detection System Based on RPA-CRISPR/Cas12a-SPM and Deep Learning
Published on: May 10, 2024
1.2K
Accurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy
Ming Xu1,2,3, Liu Ouyang4, Lei Han1,2
1Department of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
Journal of Medical Internet Research
|January 6, 2021
Summary
This study combined clinical, lab, and CT scan data to accurately diagnose COVID-19 and other pneumonias. The hybrid deep learning-machine learning model achieved high accuracy, aiding clinical decision support.
Area of Science:
- Medical Imaging
- Artificial Intelligence in Medicine
- Infectious Disease Diagnostics
Background:
- Accurate identification of COVID-19 patients using non-PCR methods is crucial for clinical outcomes.
- A comprehensive understanding of biomedical features and analytical approaches for early COVID-19 detection is lacking.
Purpose of the Study:
- To combine clinical, lab, and computed tomography (CT) imaging data to differentiate between healthy individuals, COVID-19 patients, and non-COVID viral pneumonia.
- To achieve accurate differentiation, especially during the early stages of infection.
Main Methods:
- Recruited 214 nonsevere COVID-19, 148 severe COVID-19, 198 healthy, and 129 non-COVID viral pneumonia patients.
- Utilized 3 input modalities: clinical information (23 features), lab testing results (10 features), and CT scans.
- Developed a deep learning model for CT feature extraction and integrated it with machine learning models (k-NN, random forest, SVM) using 43 combined features.
Main Results:
- Multimodal features significantly improved performance compared to single modalities.
- Machine learning models achieved high overall prediction accuracy (95.4%-97.7%).
- Class-specific prediction accuracy ranged from 90.6% to 99.9%.
Conclusions:
- The hybrid deep learning-machine learning framework offers a novel and effective approach for clinical applications, outperforming single-modality benchmarks.
- Findings from this large-scale study and analytical workflow can support clinical decision-making for COVID-19 diagnosis.
- The methodology can be applied to other clinical scenarios involving high-dimensional multimodal biomedical data.

